Cargando…
Human Fecal Microbiota Transplantation Reduces the Susceptibility to Dextran Sulfate Sodium-Induced Germ-Free Mouse Colitis
In clinical practice, fecal microbiota transplantation (FMT) has been used to treat inflammatory bowel disease (IBD), and has shown certain effects. However, the selection of FMT donors and the mechanism underlying the effect of FMT intervention in IBD require further exploration. In this study, dex...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882623/ https://www.ncbi.nlm.nih.gov/pubmed/35237276 http://dx.doi.org/10.3389/fimmu.2022.836542 |
_version_ | 1784659735732027392 |
---|---|
author | Yang, Yapeng Zheng, Xiaojiao Wang, Yuqing Tan, Xiang Zou, Huicong Feng, Shuaifei Zhang, Hang Zhang, Zeyue He, Jinhui Cui, Bota Zhang, Xueying Wu, Zhifeng Dong, Miaomiao Cheng, Wei Tao, Shiyu Wei, Hong |
author_facet | Yang, Yapeng Zheng, Xiaojiao Wang, Yuqing Tan, Xiang Zou, Huicong Feng, Shuaifei Zhang, Hang Zhang, Zeyue He, Jinhui Cui, Bota Zhang, Xueying Wu, Zhifeng Dong, Miaomiao Cheng, Wei Tao, Shiyu Wei, Hong |
author_sort | Yang, Yapeng |
collection | PubMed |
description | In clinical practice, fecal microbiota transplantation (FMT) has been used to treat inflammatory bowel disease (IBD), and has shown certain effects. However, the selection of FMT donors and the mechanism underlying the effect of FMT intervention in IBD require further exploration. In this study, dextran sodium sulfate (DSS)-induced colitis mice were used to determine the differences in the protection of colitis symptoms, inflammation, and intestinal barrier, by FMT from two donors. Intriguingly, pre-administration of healthy bacterial fluid significantly relieved the symptoms of colitis compared to the ulcerative colitis (UC) bacteria. In addition, healthy donor (HD) bacteria significantly reduced the levels of inflammatory markers Myeloperoxidase (MPO) and Eosinophil peroxidase (EPO), and various pro-inflammatory factors, in colitis mice, and increased the secretion of the anti-inflammatory factor IL-10. Metagenomic sequencing indicated higher species diversity and higher abundance of anti-inflammatory bacteria in the HD intervention group, including Alistipes putredinis, Akkermansia muciniphila, Bifidobacterium adolescentis, short-chain fatty acids (SCFAs)-producing bacterium Christensenella minuta, and secondary bile acids (SBAs)-producing bacterium Clostridium leptum. In the UC intervention group, the SCFA-producing bacterium Bacteroides stercoris, IBD-related bacterium Ruminococcus gnavus, Enterococcus faecalis, and the conditional pathogen Bacteroides caccae, were more abundant. Metabolomics analysis showed that the two types of FMT significantly modulated the metabolism of DSS-induced mice. Moreover, compared with the UC intervention group, indoleacetic acid and unsaturated fatty acids (DHA, DPA, and EPA) with anti-inflammatory effects were significantly enriched in the HD intervention group. In summary, these results indicate that FMT can alleviate the symptoms of colitis, and the effect of HD intervention is better than that of UC intervention. This study offers new insights into the mechanisms of FMT clinical intervention in IBD. |
format | Online Article Text |
id | pubmed-8882623 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88826232022-03-01 Human Fecal Microbiota Transplantation Reduces the Susceptibility to Dextran Sulfate Sodium-Induced Germ-Free Mouse Colitis Yang, Yapeng Zheng, Xiaojiao Wang, Yuqing Tan, Xiang Zou, Huicong Feng, Shuaifei Zhang, Hang Zhang, Zeyue He, Jinhui Cui, Bota Zhang, Xueying Wu, Zhifeng Dong, Miaomiao Cheng, Wei Tao, Shiyu Wei, Hong Front Immunol Immunology In clinical practice, fecal microbiota transplantation (FMT) has been used to treat inflammatory bowel disease (IBD), and has shown certain effects. However, the selection of FMT donors and the mechanism underlying the effect of FMT intervention in IBD require further exploration. In this study, dextran sodium sulfate (DSS)-induced colitis mice were used to determine the differences in the protection of colitis symptoms, inflammation, and intestinal barrier, by FMT from two donors. Intriguingly, pre-administration of healthy bacterial fluid significantly relieved the symptoms of colitis compared to the ulcerative colitis (UC) bacteria. In addition, healthy donor (HD) bacteria significantly reduced the levels of inflammatory markers Myeloperoxidase (MPO) and Eosinophil peroxidase (EPO), and various pro-inflammatory factors, in colitis mice, and increased the secretion of the anti-inflammatory factor IL-10. Metagenomic sequencing indicated higher species diversity and higher abundance of anti-inflammatory bacteria in the HD intervention group, including Alistipes putredinis, Akkermansia muciniphila, Bifidobacterium adolescentis, short-chain fatty acids (SCFAs)-producing bacterium Christensenella minuta, and secondary bile acids (SBAs)-producing bacterium Clostridium leptum. In the UC intervention group, the SCFA-producing bacterium Bacteroides stercoris, IBD-related bacterium Ruminococcus gnavus, Enterococcus faecalis, and the conditional pathogen Bacteroides caccae, were more abundant. Metabolomics analysis showed that the two types of FMT significantly modulated the metabolism of DSS-induced mice. Moreover, compared with the UC intervention group, indoleacetic acid and unsaturated fatty acids (DHA, DPA, and EPA) with anti-inflammatory effects were significantly enriched in the HD intervention group. In summary, these results indicate that FMT can alleviate the symptoms of colitis, and the effect of HD intervention is better than that of UC intervention. This study offers new insights into the mechanisms of FMT clinical intervention in IBD. Frontiers Media S.A. 2022-02-14 /pmc/articles/PMC8882623/ /pubmed/35237276 http://dx.doi.org/10.3389/fimmu.2022.836542 Text en Copyright © 2022 Yang, Zheng, Wang, Tan, Zou, Feng, Zhang, Zhang, He, Cui, Zhang, Wu, Dong, Cheng, Tao and Wei https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Yang, Yapeng Zheng, Xiaojiao Wang, Yuqing Tan, Xiang Zou, Huicong Feng, Shuaifei Zhang, Hang Zhang, Zeyue He, Jinhui Cui, Bota Zhang, Xueying Wu, Zhifeng Dong, Miaomiao Cheng, Wei Tao, Shiyu Wei, Hong Human Fecal Microbiota Transplantation Reduces the Susceptibility to Dextran Sulfate Sodium-Induced Germ-Free Mouse Colitis |
title | Human Fecal Microbiota Transplantation Reduces the Susceptibility to Dextran Sulfate Sodium-Induced Germ-Free Mouse Colitis |
title_full | Human Fecal Microbiota Transplantation Reduces the Susceptibility to Dextran Sulfate Sodium-Induced Germ-Free Mouse Colitis |
title_fullStr | Human Fecal Microbiota Transplantation Reduces the Susceptibility to Dextran Sulfate Sodium-Induced Germ-Free Mouse Colitis |
title_full_unstemmed | Human Fecal Microbiota Transplantation Reduces the Susceptibility to Dextran Sulfate Sodium-Induced Germ-Free Mouse Colitis |
title_short | Human Fecal Microbiota Transplantation Reduces the Susceptibility to Dextran Sulfate Sodium-Induced Germ-Free Mouse Colitis |
title_sort | human fecal microbiota transplantation reduces the susceptibility to dextran sulfate sodium-induced germ-free mouse colitis |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882623/ https://www.ncbi.nlm.nih.gov/pubmed/35237276 http://dx.doi.org/10.3389/fimmu.2022.836542 |
work_keys_str_mv | AT yangyapeng humanfecalmicrobiotatransplantationreducesthesusceptibilitytodextransulfatesodiuminducedgermfreemousecolitis AT zhengxiaojiao humanfecalmicrobiotatransplantationreducesthesusceptibilitytodextransulfatesodiuminducedgermfreemousecolitis AT wangyuqing humanfecalmicrobiotatransplantationreducesthesusceptibilitytodextransulfatesodiuminducedgermfreemousecolitis AT tanxiang humanfecalmicrobiotatransplantationreducesthesusceptibilitytodextransulfatesodiuminducedgermfreemousecolitis AT zouhuicong humanfecalmicrobiotatransplantationreducesthesusceptibilitytodextransulfatesodiuminducedgermfreemousecolitis AT fengshuaifei humanfecalmicrobiotatransplantationreducesthesusceptibilitytodextransulfatesodiuminducedgermfreemousecolitis AT zhanghang humanfecalmicrobiotatransplantationreducesthesusceptibilitytodextransulfatesodiuminducedgermfreemousecolitis AT zhangzeyue humanfecalmicrobiotatransplantationreducesthesusceptibilitytodextransulfatesodiuminducedgermfreemousecolitis AT hejinhui humanfecalmicrobiotatransplantationreducesthesusceptibilitytodextransulfatesodiuminducedgermfreemousecolitis AT cuibota humanfecalmicrobiotatransplantationreducesthesusceptibilitytodextransulfatesodiuminducedgermfreemousecolitis AT zhangxueying humanfecalmicrobiotatransplantationreducesthesusceptibilitytodextransulfatesodiuminducedgermfreemousecolitis AT wuzhifeng humanfecalmicrobiotatransplantationreducesthesusceptibilitytodextransulfatesodiuminducedgermfreemousecolitis AT dongmiaomiao humanfecalmicrobiotatransplantationreducesthesusceptibilitytodextransulfatesodiuminducedgermfreemousecolitis AT chengwei humanfecalmicrobiotatransplantationreducesthesusceptibilitytodextransulfatesodiuminducedgermfreemousecolitis AT taoshiyu humanfecalmicrobiotatransplantationreducesthesusceptibilitytodextransulfatesodiuminducedgermfreemousecolitis AT weihong humanfecalmicrobiotatransplantationreducesthesusceptibilitytodextransulfatesodiuminducedgermfreemousecolitis |